Pharmacokinetics pharmacodynamics and tolerability of verinurad a selective uric acid reabsorption inhibitor in healthy Japanese and non-Asian male subjects

摘要

PurposeVerinurad (RDEA3170) is a selective uric acid reabsorption inhibitor in clinical development for treatment of gout and asymptomatic hyperuricemia. This study evaluated verinurad pharmacokinetics, pharmacodynamics, and tolerability in healthy Japanese and non-Asian adult male subjects.